Filing Details
- Accession Number:
- 0000878526-21-000112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-13 17:03:18
- Reporting Period:
- 2021-12-09
- Accepted Time:
- 2021-12-13 17:03:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
878526 | Natus Medical Inc | NTUS | Electromedical & Electrotherapeutic Apparatus (3845) | 770154833 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1221306 | Christopher Chune Dong Chung | C/O Natus Medical Incorporated 6701 Koll Center Parkway, Suite 120 Pleasanton CA 94566 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2021-12-09 | 11,787 | $20.68 | 51,713 | No | 4 | M | Direct | |
Common Stock, $0.001 Par Value Per Share | Disposition | 2021-12-09 | 11,787 | $23.08 | 39,926 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Nonqualified Stock Option | Disposition | 2021-12-09 | 11,787 | $20.68 | 11,787 | $20.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
35,360 | 2021-11-13 | 2030-11-13 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $22.95 to $23.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.